Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 15, 2019 | CMO | 241 | $165.41 | Sell | $39,863.81 | |
| May 15, 2019 | EVP | 61 | $165.41 | Sell | $10,090.01 | |
| May 6, 2019 | CEO | 33,058 | $175.01 | Sell | $5,785,480.58 | |
| May 3, 2019 | EVP | 1,622 | $172.06 | Sell | $279,081.32 | |
| May 1, 2019 | CEO | 10,480 | $175.08 | Sell | $1,834,838.40 | |
| April 15, 2019 | EVP | 5,624 | $181.75 | Sell | $1,022,162.00 | |
| Feb. 19, 2019 | SVP | 2,812 | $186.97 | Sell | $525,759.64 | |
| Feb. 19, 2019 | EVP | 5,624 | $187.00 | Sell | $1,051,688.00 | |
| Feb. 19, 2019 | CMO | 1,488 | $186.94 | Sell | $278,166.72 | |
| Feb. 19, 2019 | CEO | 20,997 | $186.98 | Sell | $3,926,019.06 | |
| Feb. 11, 2019 | EVP | 12,136 | $180.22 | Sell | $2,187,149.92 | |
| Feb. 11, 2019 | SVP | 4,215 | $180.16 | Sell | $759,374.40 | |
| Feb. 11, 2019 | CEO | 111,431 | $180.24 | Sell | $20,084,323.44 | |
| Feb. 6, 2019 | SVP | 1,289 | $193.00 | Sell | $248,777.00 | |
| Feb. 4, 2019 | SVP | 4,247 | $187.02 | Sell | $794,273.94 | |
| Feb. 4, 2019 | EVP | 2,330 | $189.19 | Sell | $440,812.70 | |
| Feb. 4, 2019 | CEO | 32,250 | $186.35 | Sell | $6,009,787.50 | |
| Feb. 1, 2019 | EVP | 3,450 | $190.92 | Sell | $658,674.00 | |
| Jan. 22, 2019 | EVP | 2,125 | $193.48 | Sell | $411,145.00 | |
| Jan. 18, 2019 | EVP | 1,223 | $194.62 | Sell | $238,020.26 | |
| Jan. 17, 2019 | SVP | 3,007 | $190.62 | Sell | $573,194.34 | |
| Jan. 14, 2019 | EVP | 2,125 | $186.71 | Sell | $396,758.75 | |
| Jan. 4, 2019 | EVP | 4,250 | $165.90 | Sell | $705,075.00 | |
| Dec. 3, 2018 | SVP | 809 | $186.52 | Sell | $150,894.68 | |
| Nov. 15, 2018 | EVP | 100 | $163.75 | Sell | $16,375.00 | |
| Nov. 15, 2018 | SVP | 12 | $163.75 | Sell | $1,965.00 | |
| Nov. 7, 2018 | EVP | 2,125 | $181.89 | Sell | $386,516.25 | |
| Nov. 5, 2018 | EVP | 4,126 | $173.51 | Sell | $715,902.26 | |
| Nov. 2, 2018 | EVP | 2,155 | $175.36 | Sell | $377,900.80 | |
| Oct. 12, 2018 | EVP | 2,125 | $177.20 | Sell | $376,550.00 | |
| Oct. 8, 2018 | CMO | 2,305 | $186.95 | Sell | $430,919.75 | |
| Oct. 4, 2018 | EVP | 4,250 | $191.58 | Sell | $814,215.00 | |
| Oct. 3, 2018 | Director | 6,818 | $192.13 | Sell | $1,309,942.34 | |
| Oct. 1, 2018 | CFO | 1,076 | $193.24 | Sell | $207,926.24 | |
| Oct. 1, 2018 | EVP | 2,445 | $194.62 | Sell | $475,845.90 | |
| Aug. 28, 2018 | EVP | 2,125 | $181.89 | Sell | $386,516.25 | |
| Aug. 3, 2018 | EVP | 10,083 | $175.29 | Sell | $1,767,449.07 | |
| Aug. 3, 2018 | SVP | 2,098 | $174.44 | Sell | $365,975.12 | |
| July 16, 2018 | EVP | 8,500 | $179.21 | Sell | $1,523,285.00 | |
| July 16, 2018 | SVP | 860 | $179.85 | Sell | $154,671.00 | |
| July 12, 2018 | EVP | 2,125 | $175.02 | Sell | $371,917.50 | |
| July 12, 2018 | SVP | 860 | $175.02 | Sell | $150,517.20 | |
| July 5, 2018 | EVP | 4,250 | $168.38 | Sell | $715,615.00 | |
| June 29, 2018 | EVP | 4,096 | $167.63 | Sell | $686,612.48 | |
| June 29, 2018 | SVP | 2,957 | $166.52 | Sell | $492,399.64 | |
| June 29, 2018 | COO | 23,375 | $166.30 | Sell | $3,887,262.50 | |
| June 22, 2018 | COO | 4,250 | $160.00 | Sell | $680,000.00 | |
| June 22, 2018 | CEO | 140,211 | $160.00 | Sell | $22,433,760.00 | |
| June 4, 2018 | Director | 875 | $152.05 | Sell | $133,043.75 | |
| May 15, 2018 | EVP | 138 | $155.78 | Sell | $21,497.64 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.